REPEAT SCREENING ADHERENCE

High adherence continues after an initial Cologuard® test screening1,2

Cologuard patients are likely to adhere to follow-up colonoscopy and future screening1,2

Separate studies demonstrated outcomes after positive and negative Cologuard results.

After a positive test result:

79%

of patients were adherent to a follow-up
colonoscopy.1*

After a negative test result:

83%

of patients were adherent to their second Cologuard screening after 3 years2†

94%

of patients were adherent to their third Cologuard screening after 6 years2†

Offer the Cologuard test to average-risk patients as defined by the United States Preventive Services Task Force and prioritize colonoscopy for those who need it most.3-5

Cologuard box.

Better outcomes with the Cologuard test

Discover adherence data for initial screening with the Cologuard test.

View The Data

Screen your eligible patients for colorectal cancer (CRC) every 3 years with the Cologuard test to help increase adherence1,5,6

Send the Cologuard Rescreening Letter to your patients when they become eligible for rescreening with the Cologuard test

Download

Patients are eligible for rescreening with the Cologuard test if they5-7:

Are aged 45 years or older

Are at average risk for CRC

Received a negative test result with previous Cologuard screening

PROVIDER STATUS REPORT

Get screening updates for your eligible patients

Sign up for biweekly fax updates summarizing which of your patients are due for rescreening with the Provider Status Report Enrollment Form. Forms are available for both single and multiple office locations.

Single Location Form
Multiple Location Form

Follow-up colonoscopy quality

Discover the impact of a positive Cologuard result on colonoscopy quality

Explore The Data
  • *Continuous enrollment was required for ≥1 years after a positive stool-based test until the end of disenrollment, 3 months after a claim indicating high-risk criteria, or end of the study period.1
  • †Based on a retrospective cohort study of 481,748 patients aged 45-75 who received a Cologuard kit between January 1 and December 31, 2023, and who had received a negative Cologuard result at least 2.5 years ago.2